Nadine Kumpesa

3PUBLICATIONS
39CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 01, 2026
Safety and activity of RO7300490, a bispecific CD40 agonist targeted to fibroblast activation protein, in patients with advanced solid tumors: a single-arm, multicenter, first-in-human, phase 1 trial.

|Apr 21, 2026
FAP-Targeted LTβR Agonist Drives HEV Differentiation and Immune Niche Formation for Improved Immunotherapy Response in Solid Tumors.

|Mar 12, 2026
Spatial transcriptomics and single-nucleus RNA sequencing reveal rAAV2- and rAAV9-specific transduction signatures in the mouse liver.

Bettina Amberg, Fabian Köchl, Nadine Kumpesa

Pageof 1

Frequent Collaborators

3 joint publications

Petra C Schwalie

1 joint publications

Bettina Amberg

1 joint publications

Michael B Otteneder

1 joint publications

Hélène Haegel